Can molecular genetics help in the clinic?

Can molecular genetics help in the clinic? Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Can molecular genetics help in the clinic? Abstract Text:

Can molecular genetics help in the clinic? Publishing Authors By Initials

For similar proteins: transcription factors research abstracts see: proteins: transcription factors research

PUBMED ID PMID:

MEDLINE DATE:

Can molecular genetics help in the clinic? Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Diabetic medicine : a journal of the British Diabe

VOLUME: 16

Page Numbers: 788-91

Journal Abbreviation: Diabet. Med.

ISSN: 0742-3071

DAY: 14

MONTH: Sep

YEAR: 1999

Can molecular genetics help in the clinic? Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8500858

Can molecular genetics help in the clinic? Keywords Mesh Terms:

KEYWORDS: Transcription Factors

MESH TERMS: genetics

Chemical & Substance for Abstract: Can molecular genetics help in the clinic? Information

Substance Name: Glucokinase

Registry Number: EC 2.7.1.2

Grant and Affiliation Information for Can molecular genetics help in the clinic?

AFFILIATION: Dept of Diabetes and Vascular Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, UK.

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Diabet Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Can molecular genetics help in the clinic? Related Publications

• 'I don't feel like a diabetic any more': the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing.
• A severe clinical phenotype results from the co-inheritance of type 2 susceptibility genes and a hepatocyte nuclear factor-1alpha mutation.
• Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.
• Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers.
• Blood transfusions and the Rh factor.
• Can molecular genetics help in the clinic?
• Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation.
• Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes.
• Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations.
• Diagnosis of maturity-onset diabetes of the young in the pediatric diabetes clinic.
• Different genes, different diabetes: lessons from maturity-onset diabetes of the young.
• Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
• Genetics and type 2 diabetes in youth.
• Heterogeneity in young adult onset diabetes: aetiology alters clinical characteristics.
• Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes.
• Impaired maximum microvascular hyperaemia in patients with MODY 3 (hepatocyte nuclear factor-1alpha gene mutations).
• Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers.
• Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.
• Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.
• Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization.
• Mutations in hepatocyte nuclear factor 1beta are not a common cause of maturity-onset diabetes of the young in the U.K.
• Mutations in the glucokinase gene of the fetus result in reduced placental weight.
• No evidence for linkage at candidate type 2 diabetes susceptibility loci on chromosomes 12 and 20 in United Kingdom Caucasians.
• Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young.
• Proposed mechanism for a novel insertion/deletion frameshift mutation (I414G415ATCG-->CCA) in the hepatocyte nuclear factor 1 alpha (HNF-1 alpha) gene which causes maturity-onset diabetes of the young (MODY).
• Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.
• Serum amino acids in patients with mutations in the hepatocyte nuclear factor-1 alpha gene.
• The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria.
• beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.
• beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.